Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Distinct mesenchymal cell states mediate prostate cancer progression (mouse)

ABSTRACT: Distinct mesenchymal cell states mediate prostate cancer progression (mouse)

PROVIDER: PRJNA1022038 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26213700.fastq.gz	Fastqsanger.gz
	SRR26213701.fastq.gz	Fastqsanger.gz
	SRR26213702.fastq.gz	Fastqsanger.gz
	SRR26213703.fastq.gz	Fastqsanger.gz
	SRR26213704.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 48

Similar Datasets

Distinct mesenchymal cell states mediate prostate cancer progression

Project description:Distinct mesenchymal cell states mediate prostate cancer progression

| PRJNA1022035 | ENA

Distinct mesenchymal cell states mediate prostate cancer progression (human)

Project description:Distinct mesenchymal cell states mediate prostate cancer progression (human)

| PRJNA1022036 | ENA

Distinct mesenchymal cell states mediate prostate cancer progression [Spatial Transcriptomics]

Project description:Distinct mesenchymal cell states mediate prostate cancer progression [Spatial Transcriptomics]

| PRJNA1044082 | ENA

Distinct mesenchymal cell states mediate prostate cancer progression (mouse)

Project description:We sought to determine whether molecular alterations in tumor stroma influence prostate cancer progression and metastatic potential. To accomplish this, we compared mesenchymal cells from four genetically engineered mouse models (GEMMs) of prostate cancer representing different stages of the disease to their wild-type (WT) counterparts by single-cell RNA sequencing (scRNA-seq) and, ultimately, to human tumors with comparable genotypes. We identified 8 transcriptionally and functionally distinct stromal populations responsible for both common and GEMM-specific transcriptional programs. These are conserved between mouse models and human prostate cancers with the same genomic drivers. The transcriptional profiles of the stroma of murine models of advanced disease were similar to those of human prostate cancer bone metastases, with periostin expression by stromal cells influencing invasion and neuroendocrine differentiation. These profiles were then used to build a robust gene signature that can predict metastatic progression in localized disease independent of Gleason score. Taken together, this offers new evidence that the stromal microenvironment mediates prostate cancer progression.

2023-10-10 | GSE244269 | GEO

Distinct mesenchymal cell states mediate prostate cancer progression (human)

2023-10-10 | GSE244267 | GEO

Distinct mesenchymal cell states mediate prostate cancer progression [Spatial Transcriptomics]

2023-12-01 | GSE248466 | GEO

Distinct mesenchymal cell states mediate prostate cancer progression.

Project description:Alterations in tumor stroma influence prostate cancer progression and metastatic potential. However, the molecular underpinnings of this stromal-epithelial crosstalk are largely unknown. Here, we compare mesenchymal cells from four genetically engineered mouse models (GEMMs) of prostate cancer representing different stages of the disease to their wild-type (WT) counterparts by single-cell RNA sequencing (scRNA-seq) and, ultimately, to human tumors with comparable genotypes. We identified 8 transcriptionally and functionally distinct stromal populations responsible for common and GEMM-specific transcriptional programs. We show that stromal responses are conserved in mouse models and human prostate cancers with the same genomic alterations. We noted striking similarities between the transcriptional profiles of the stroma of murine models of advanced disease and those of of human prostate cancer bone metastases. These profiles were then used to build a robust gene signature that can predict metastatic progression in prostate cancer patients with localized disease and is also associated with progression-free survival independent of Gleason score. Taken together, this offers new evidence that stromal microenvironment mediates prostate cancer progression, further identifying tissue-based biomarkers and potential therapeutic targets of aggressive and metastatic disease.

| S-EPMC10081210 | biostudies-literature

Distinct mesenchymal cell states mediate prostate cancer progression.

Project description:In the complex tumor microenvironment (TME), mesenchymal cells are key players, yet their specific roles in prostate cancer (PCa) progression remain to be fully deciphered. This study employs single-cell RNA sequencing to delineate molecular changes in tumor stroma that influence PCa progression and metastasis. Analyzing mesenchymal cells from four genetically engineered mouse models (GEMMs) and correlating these findings with human tumors, we identify eight stromal cell populations with distinct transcriptional identities consistent across both species. Notably, stromal signatures in advanced mouse disease reflect those in human bone metastases, highlighting periostin's role in invasion and differentiation. From these insights, we derive a gene signature that predicts metastatic progression in localized disease beyond traditional Gleason scores. Our results illuminate the critical influence of stromal dynamics on PCa progression, suggesting new prognostic tools and therapeutic targets.

| S-EPMC10774315 | biostudies-literature

Distinct mesenchymal cell states mediate prostate cancer progression

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-10-10 | GSE244270 | GEO

Profiling of prostate tissues in prostate cancer progression

Project description:Samples of benign prostate tissue, localized prostate cancer tissue, and metastatic prostate cancer tissue are profiled to study expression changes in diagnosis and progression of prostate cancer. Each tissue sample is also profiled for metabolomics data Keywords: Cancer Progression 41 samples were analyzed (16 benign prostate tissue, 12 local prostate cancer tissue, 13 metastatic prostate cancer tissue)

2011-03-30 | E-GEOD-8511 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data